EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Milind Y Desai iD, Anjali T Owens, Theodore Abraham, Iacopo Olivotto iD, Pablo Garcia-Pavia, Renato D Lopes, Perry Elliott iD, Fabio Fernandes, Nicolas Verheyen, Lars Maier, Benjamin Meder, Olga Azevedo iD und 14 weitere

New England Journal of Medicine · 11.09.2025 · 393 (10) · 961-972

DOI: 10.1056/nejmoa2505927 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 11.09.2025. Verfasst von Milind Y Desai und 25 weiteren Autor:innen. Beteiligte Einrichtung: Hypertrophic Cardiomyopathy Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Stroke Volume, Benzylamines. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bristol Myers Squibb Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicStroke VolumeBenzylaminesAdultAgedFemaleHumansMaleMiddle AgedDouble-Blind MethodOxygen ConsumptionUracilTreatment OutcomeEchocardiographyExercise Test

Substanzen

MYK-461UracilBenzylamines

Autor:innen und Institutionen

  • Hypertrophic Cardiomyopathy Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland.
  • Cleveland Clinic Coordinating Center for Clinical Research, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland.
  • Department of Cardiology, University of Pennsylvania, Philadelphia.
  • Department of Cardiology, University of, California, San Francisco, San Francisco.
  • Department of Cardiology, Meyer Children's Hospital, IRCCS, Florence, Italy.
  • Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, and Centr…

ORCID-Profile: Milind Y Desai, Iacopo Olivotto, Perry Elliott, Olga Azevedo, Steven E Nissen

Förderung

  • Bristol Myers Squibb Foundation

Zitieren

APA

Desai, M. Y., Owens, A. T., Abraham, T., Olivotto, I., Garcia-Pavia, P., Lopes, R. D., Elliott, P., Fernandes, F., Verheyen, N., Maier, L., Meder, B., Azevedo, O., Kitaoka, H., Wolski, K., Wang, Q., Jaber, W., Mitchell, L., Myers, J., Rano, T., …, & ODYSSEY-HCM Investigators (2025). Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine, 393(10), 961-972. https://doi.org/10.1056/nejmoa2505927

Vancouver

Desai MY, Owens AT, Abraham T, Olivotto I, Garcia-Pavia P, Lopes RD, et al. Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. 2025;393(10):961-972. doi:10.1056/nejmoa2505927

BibTeX
@article{Desai2025,
  author = {Desai, Milind Y and Owens, Anjali T and Abraham, Theodore and Olivotto, Iacopo and Garcia-Pavia, Pablo and Lopes, Renato D and Elliott, Perry and Fernandes, Fabio and Verheyen, Nicolas and Maier, Lars and Meder, Benjamin and Azevedo, Olga and Kitaoka, Hiroaki and Wolski, Kathy and Wang, Qiuqing and Jaber, Wael and Mitchell, Lisa and Myers, Jonathan and Rano, Thomas and Gong, Zhiqun and Zhong, Yue and Carter-Bonanza, Suzanne and Florea, Victoria and Aronson, Ron and Nissen, Steven E and ODYSSEY-HCM Investigators, ODYSSEY-HCM Investigators},
  title = {Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {10},
  pages = {961--972},
  doi = {10.1056/nejmoa2505927}
}
Kostenlos starten →